Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cell Homing
100%
In Situ
100%
Controlled Release
100%
Stromal Cell-derived factor-1 (SDF-1)
100%
Infarcted Heart
100%
Stromal Cell-derived Factor
100%
C-kit Cells
100%
Fibrin Patch
50%
PEGylated Fibrin
50%
Acute Myocardial Infarction
33%
Left Ventricular Function
25%
Stem Cells
16%
Stem Cell Homing
16%
Recombinant Mice
16%
Infarct Area
16%
PEGylated Fibrinogen
16%
Western Blotting
8%
Post-acute
8%
Spinocerebellar Ataxia
8%
Myocardium
8%
Bone Marrow
8%
Infarction
8%
Post-infarction
8%
Engraftment
8%
Left Ventricle
8%
Ischemic Myocardium
8%
Polyethylene Glycol
8%
Potential Therapeutics
8%
Peripheral Blood
8%
Left Ventricular Remodeling
8%
Enzyme-linked Immunosorbent Assay (ELISA)
8%
Covalently Bound
8%
Infarct
8%
Limited Time
8%
Release Kinetics
8%
Infarct Size
8%
Left Anterior Descending Artery
8%
Thrombin
8%
Therapeutic Implications
8%
Stem Cell Recruitment
8%
Ligature
8%
Acute Myocardial Infarction Model
8%
Home Factors
8%
Co-immunoprecipitation (co-IP)
8%
Patch-based
8%
Pharmacology, Toxicology and Pharmaceutical Science
Controlled Release
100%
Stromal Cell Derived Factor 1alpha
100%
Fibrin
46%
Acute Heart Infarction
38%
Infarction
38%
Fibrinogen
15%
Enzyme-Linked Immunosorbent Assay
7%
Immunoprecipitation
7%
Western Blot
7%
Macrogol Derivative
7%
Heart Muscle Ischemia
7%
Heart Ventricle Remodeling
7%
Macrogol
7%
Thrombin
7%